PCI vs CABG for LM disease in ACS and non-ACS patients: an integrated analysis of randomized trials
An integrated analysis of randomized trials comparing PCI and CABG for LM disease found no difference in all-cause mortality at 5 years after treatment with PCI versus CABG in patients with or without ACS. Dr. Prakriti Gaba and colleagues of Brigham and Women's Hospital, USA, reported in the online edition of JAMA Cardiology.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations